Long term I still say we are on an uptrend. But don't expect any wild jumps until middle of next year. Some holders seem to want to judge KTD by the waking minute.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025